InFocus - Life Sciences & Healthcare e-newsletter - April 2010
06 avril. 2010 | Sciences de la vie & Santé
In the April issue of InFocus we discuss:
- Corporate venturing in the LSH industry
- ECJ Advocate General attempts to limit scope of DNA patents
- Social media channels - a new world of opportunity?
- A different approach - UK Court of Appeal does not follow EPO in Eli Lilly v HGS
Avocats Christoph de Coster, Dr. Gisbert Hohagen, Saufung Ma, Dr. Wolfgang Rehmann, Matthew Royle, Tim Worden
In Brief we discuss:
- Germany: SPC for medical device containing a medicinal product
- SPCs for combination products - new UK decisions
- Claims encompassing substantial surgical interventions are excluded from patentability
- Dosage regime claims allowed and Swiss type claims abolished
- Bioequivalence - new revised guidance published
- Next round in the debate about Zero Term SPCs
- Execution of documents at virtual signings: Law Society practice notice
- IP licence termination and the anti-deprivation principle - an update Butters v BBC Worldwide
- Amendment to medical devices legislation in Germany
- OFT investigates Reckitt Benckiser
